Abstract:The adenoviral early region 1A (E1A) protein has proapoptotic and angiogenic activity, along with its chemosensitizing effect, making it the focus of increased interest in the context of cancer therapy. It was previously shown that E1A-induced chemosensitization to different drugs, including histone deacetylases inhibitors (HDACi), appears to be mediated by Forkhead box O (FoxO) transcription factors. In this study, we explore the relationship between E1A expression and the modulation of FoxO activity with HDA… Show more
“…It has been shown that E1A sensitizes tumor cells with respect to HDIs (SAHA, TSA) more effectively than with respect to other chemotherapy drugs (5-fluorouracil, cisplatin, etoposide, or paclitaxel) [ 13 ]. However, as we have shown earlier, HDI induced degradation of E1A [ 15 ].…”
Section: Introductionmentioning
confidence: 59%
“…Показано, что сенсибилизирующий эффект E1A в отношении цитотоксического действия ИГД (SAHA, TSA) сильнее, чем других химиотерапевтических препаратов (5-фторурацил, цисплатин, этопозид, паклитаксел) [13]. Однако, как показано нами ранее, действие ИГД приводит к деградации Е1А [15].…”
Section: Introductionunclassified
“…Ранее нами были отмечены различия в интенсивности ИГД-индуцированной деградации белка E1A в клетках, экспрессирующих Ras дикого типа или мутантный белок, что дало нам возможность выдвинуть предположение о роли белка Ras в регуляции стабильности E1A [15]. Малая GTP-аза Ras является ключевым регулятором клеточного роста [22].…”
Section: Introductionunclassified
“…Previously, we showed that there was a difference in the dynamics of HDI-induced E1A degradation in cells expressing wild-type Ras or a mutant Ras protein [ 15 ]. These observations suggest that there is a role played by the Ras protein in the regulation of E1A stability.…”
The E1A adenoviral protein required for the initiation of the viral life cycle is being actively studied as a sensitizing agent in the combination therapy of cancer, and tumors with activated Ras in particular. We investigated the role played by the Ras signaling pathway in the regulation of E1A protein stability and showed that overexpression of activated Ras increases the basal level of E1A, but enhances the degradation of the E1A protein under treatment with histone deacetylase inhibitors (HDIs). It has been found that the MAP kinase ERK is the key factor in E1A stabilization, and ERK inactivation upon HDI treatment reduces the E1A protein level. Our results indicate that the combination treatment of tumors with activated Ras using adenoviral E1A and HDI has limitations attributed to intense HDI-dependent degradation of E1A. Nevertheless, the established contribution of ERK kinase to the regulation of E1A stability can be used to search for new effective drug combinations based on the adenoviral E1A protein.
“…It has been shown that E1A sensitizes tumor cells with respect to HDIs (SAHA, TSA) more effectively than with respect to other chemotherapy drugs (5-fluorouracil, cisplatin, etoposide, or paclitaxel) [ 13 ]. However, as we have shown earlier, HDI induced degradation of E1A [ 15 ].…”
Section: Introductionmentioning
confidence: 59%
“…Показано, что сенсибилизирующий эффект E1A в отношении цитотоксического действия ИГД (SAHA, TSA) сильнее, чем других химиотерапевтических препаратов (5-фторурацил, цисплатин, этопозид, паклитаксел) [13]. Однако, как показано нами ранее, действие ИГД приводит к деградации Е1А [15].…”
Section: Introductionunclassified
“…Ранее нами были отмечены различия в интенсивности ИГД-индуцированной деградации белка E1A в клетках, экспрессирующих Ras дикого типа или мутантный белок, что дало нам возможность выдвинуть предположение о роли белка Ras в регуляции стабильности E1A [15]. Малая GTP-аза Ras является ключевым регулятором клеточного роста [22].…”
Section: Introductionunclassified
“…Previously, we showed that there was a difference in the dynamics of HDI-induced E1A degradation in cells expressing wild-type Ras or a mutant Ras protein [ 15 ]. These observations suggest that there is a role played by the Ras protein in the regulation of E1A stability.…”
The E1A adenoviral protein required for the initiation of the viral life cycle is being actively studied as a sensitizing agent in the combination therapy of cancer, and tumors with activated Ras in particular. We investigated the role played by the Ras signaling pathway in the regulation of E1A protein stability and showed that overexpression of activated Ras increases the basal level of E1A, but enhances the degradation of the E1A protein under treatment with histone deacetylase inhibitors (HDIs). It has been found that the MAP kinase ERK is the key factor in E1A stabilization, and ERK inactivation upon HDI treatment reduces the E1A protein level. Our results indicate that the combination treatment of tumors with activated Ras using adenoviral E1A and HDI has limitations attributed to intense HDI-dependent degradation of E1A. Nevertheless, the established contribution of ERK kinase to the regulation of E1A stability can be used to search for new effective drug combinations based on the adenoviral E1A protein.
“…However, stress-induced FOXO1 acetylation also arrests FOXO1 ubiquitination and prevents FOXO1 degradation through the ubiquitin-proteasome pathway[ 48 ]. Importantly, acetylation of FOXOs is a reversible process and can be eliminated by histone acetyltransferases and histone deacetylases (HDACs)[ 49 , 50 ]. For example, Sirt1, a class III HDAC, can deacetylate FOXOs and increase their transcription[ 47 ].…”
Section: Characteristics Of Foxo Family Membersmentioning
Gastric cancer (GC) is the fifth most diagnosed cancer and the third leading cause of cancer-related death worldwide. Although progress has been made in diagnosis, surgical resection, systemic chemotherapy, and immunotherapy, patients with GC still have a poor prognosis. The overall 5-year survival rate in patients with advanced GC is less than 5%. The FOXO subfamily, of the forkhead box family of transcription factors, consists of four members, FOXO1, FOXO3, FOXO4, and FOXO6. This subfamily plays an important role in many cellular processes, such as cell cycle, cell growth, apoptosis, autophagy, stress resistance, protection from aggregate toxicity, DNA repair, tumor suppression, and metabolism, in both normal tissue and malignant tumors. Various studies support a role for FOXOs as tumor suppressors based on their ability to inhibit angiogenesis and metastasis, and promote apoptosis, yet several other studies have shown that FOXOs might also promote tumor progression in certain circumstances. To elucidate the diverse roles of FOXOs in GC, this article systematically reviews the cellular functions of FOXOs in GC to determine potential therapeutic targets and treatment strategies for patients with GC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.